|
|
 |
|
ALNY: Alnylam Pharmaceuticals Inc - Detailed Stock Quote |
Enter Ticker:
|
|
| Last |
16.44 |
|
Bid / Size |
16.44x200 |
| Net |
 -0.51 |
Ask / Size |
16.45x200 |
| % Change |
-3.01 |
52 Wk High |
26.36 |
| High |
16.86 |
52 Wk Low |
14.82 |
| Low |
16.25 |
Volume |
198,832 |
| |
| Insider Ownership |
5.8% |
|
S&P 500 Member |
NO |
| Institutional Ownership |
60.68% |
Beta |
1.24 |
| P/E (TTM) |
|
PEG Ratio |
|
| PE (forward) |
|
Price / Sales |
7.19 |
| |
| Dividend |
N/A |
| Dividend Yield |
0 |
| Last Dividend Date |
N/A |
| 5 Year Avg. Yield |
0 |
| Dividend Payout Ratio |
|
|
|
| Shares Outstanding |
41,815,000 |
| Market Capitalization |
687,438,600 |
| Last Split Date |
N/A |
| Split Factor |
N/A |
| Short Interest Ratio |
38.72 |
|
| |
| % Change |
| 4 Weeks |
-8.03 |
| 12 Weeks |
-24.5 |
| 52 Weeks |
-5.68 |
|
|
| % Change Relative to S&P 500 |
| 4 Weeks |
-10.25 |
| 12 Weeks |
-29.78 |
| 52 Weeks |
-31.79 |
|
|
Sponsored Links 
-0.51